Common Diabetes Drug Causes Bone Loss – Medical Profession in a Funk

The commonly used and much maligned diabetes drug, Avandia, just took another spill down the stairs. A new mouse study shows that the drug weakens bones and is likely to cause osteoporosis in the millions of users in the United States. The drug was shown to get directly in the way of healthy bone function, causing accelerated bone loss and slowed bone growth.

Senior study author Ron Evans, not wanting to step on GlaxoSmithKline’s toes, had this to say about Avandia “We do not recommend that people stop their treatment. You must balance the benefits against the complications."

So how do the millions of people taking this drugs balance the risks against the benefits? Well maybe they go to the FDA website where they will find that in May the FDA warned of “a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia.” Yes, that is a 43% increased risk.

So now we have a drug that causes serious bone disease and heart disease. The FDA has left it on the market so that you the consumer and your too-busy doctor can sort out if this poison is right for you.

The drug-pushing quick-fix paradigm of Western Medicine, existing almost solely to prop up the profits of multi-national drug companies and rape the American public of wealth, is a scam gone wild.

Doctors are overworked and generally inept at fixing anything without drugs, especially a complex and labor-intensive problem like diabetes. Consumers are naive to think that years of poor choices and a polluted food supply can be fixed by drugs.

Diabetes is a project. There are no quick fixes. Individuals must be consistent with many healthy habits if they are to have a chance of recovering their health.